Veterans Affairs Canada: Feasibility of IV Ketamine for the Treatment of Traumatic Brain Injury and Depression
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $225,000 over two years.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
February 26, 2024Sponsor Deadline:
March 11, 2024Description:
This opportunity supports research to evaluate the use of ketamine assisted therapy (KAT) for the treatment of mild traumatic brain injury (mTBI) and related mental health concerns. The purpose of the interventional study is to perform a pragmatic clinical trial to assess the effectiveness of IV KAT in a cohort of female and male CAF members/Veterans and civilian patients suffering from mild TBI with post-concussive symptoms and/or comorbid depression.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.